BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28656004)

  • 1. Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1α.
    Pan Y; Shao D; Zhao Y; Zhang F; Zheng X; Tan Y; He K; Li J; Chen L
    Int J Biol Sci; 2017; 13(6):794-803. PubMed ID: 28656004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine Enhances Chemosensitivity and Induces Apoptosis Through Dose-orchestrated AMPK Signaling in Breast Cancer.
    Pan Y; Zhang F; Zhao Y; Shao D; Zheng X; Chen Y; He K; Li J; Chen L
    J Cancer; 2017; 8(9):1679-1689. PubMed ID: 28775788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation.
    Seo K; Seo S; Ki SH; Shin SM
    Free Radic Biol Med; 2016 Dec; 101():511-523. PubMed ID: 27840318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human recombinant FSH induces chemoresistance in human breast cancer cells via HIF-1α activation†.
    Bergandi L; Canosa S; Pittatore G; Silvagno F; Doublier S; Gennarelli G; Benedetto C; Revelli A
    Biol Reprod; 2019 Jun; 100(6):1521-1535. PubMed ID: 30939201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines.
    Fu P; Du F; Chen W; Yao M; Lv K; Liu Y
    Oncol Rep; 2014 Jun; 31(6):2561-8. PubMed ID: 24737252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of mitochondrial DNA impairs chemical hypoxia-induced autophagy in liver tumor cells through ROS-AMPK-ULK1 signaling dysregulation independently of HIF-1α.
    Marin JJG; Lozano E; Perez MJ
    Free Radic Biol Med; 2016 Dec; 101():71-84. PubMed ID: 27687210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.
    Kazi AA; Gilani RA; Schech AJ; Chumsri S; Sabnis G; Shah P; Goloubeva O; Kronsberg S; Brodie AH
    Breast Cancer Res; 2014 Jan; 16(1):R15. PubMed ID: 24472707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells.
    Xu S; Yu C; Ma X; Li Y; Shen Y; Chen Y; Huang S; Zhang T; Deng W; Wang Y
    Eur J Pharmacol; 2021 Mar; 894():173817. PubMed ID: 33345849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.
    Zhou X; Chen J; Yi G; Deng M; Liu H; Liang M; Shi B; Fu X; Chen Y; Chen L; He Z; Wang J; Liu J
    Oncotarget; 2016 Jan; 7(1):873-84. PubMed ID: 26621849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.
    Ghattass K; El-Sitt S; Zibara K; Rayes S; Haddadin MJ; El-Sabban M; Gali-Muhtasib H
    Mol Cancer; 2014 Jan; 13():12. PubMed ID: 24461075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha.
    Adamski J; Price A; Dive C; Makin G
    PLoS One; 2013; 8(6):e65304. PubMed ID: 23785417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sanguinarine combats hypoxia-induced activation of EphB4 and HIF-1α pathways in breast cancer.
    Su Q; Wang J; Wu Q; Ullah A; Ghauri MA; Sarwar A; Chen L; Liu F; Zhang Y
    Phytomedicine; 2021 Apr; 84():153503. PubMed ID: 33636580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1α inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein.
    Chen J; Ding Z; Peng Y; Pan F; Li J; Zou L; Zhang Y; Liang H
    PLoS One; 2014; 9(6):e98882. PubMed ID: 24901645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between HIF-1α and AMPK in the regulation of cellular hypoxia adaptation in chronic kidney disease.
    Li H; Satriano J; Thomas JL; Miyamoto S; Sharma K; Pastor-Soler NM; Hallows KR; Singh P
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F414-28. PubMed ID: 26136559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.
    Li Z; Zhu Q; Hu L; Chen H; Wu Z; Li D
    Cancer Sci; 2015 Aug; 106(8):1041-9. PubMed ID: 26079208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Inhibition of MCT4 Reduces 4-Hydroxytamoxifen Sensitivity by Increasing HIF-1α Protein Expression in ER-Positive MCF-7 Breast Cancer Cells.
    Nadai T; Narumi K; Furugen A; Saito Y; Iseki K; Kobayashi M
    Biol Pharm Bull; 2021; 44(9):1247-1253. PubMed ID: 34471053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular ATP promotes breast cancer chemoresistance via HIF-1α signaling.
    Yang H; Geng YH; Wang P; Zhang HQ; Fang WG; Tian XX
    Cell Death Dis; 2022 Mar; 13(3):199. PubMed ID: 35236823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis.
    Nardinocchi L; Puca R; Sacchi A; D'Orazi G
    Mol Cancer; 2009 Jan; 8():1. PubMed ID: 19128456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.